WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma

WW domain-binding protein 2 (WBP2) has been demonstrated as oncogenic in breast cancer. Many studies have revealed the WBP2 gene as a high-risk gene for leukoariaosis and cerebral white matter lesions is important in the pathologic stage of glioma development. This study aimed to illustrate the unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuai, Zhang, Ya, Wang, Han, Zeng, Yu-Ying, Li, Zhi, Li, Ming-Li, Li, Fang-Fang, You, Jun, Zhang, Zhi-Ming, Tzeng, Chi-Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832848/
https://www.ncbi.nlm.nih.gov/pubmed/29497031
http://dx.doi.org/10.1038/s41419-018-0376-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832848/
https://www.ncbi.nlm.nih.gov/pubmed/29497031
http://dx.doi.org/10.1038/s41419-018-0376-5

Ejemplares similares